TGFB1 and neoplasm: We and others have shown that cytokines such as TGF-β can drive a phenotypical modulation of TAN from N1 (anti-tumor) to N2 (pro-tumor) [21,22,23], as well as modulating NDN to become LDN [16,17,47].